P
Payal Kapur
Researcher at University of Texas Southwestern Medical Center
Publications - 244
Citations - 11224
Payal Kapur is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Clear cell renal cell carcinoma & Cancer. The author has an hindex of 42, co-authored 223 publications receiving 8743 citations. Previous affiliations of Payal Kapur include University of Texas at Dallas & University of California, Berkeley.
Papers
More filters
Journal ArticleDOI
Discriminative Spectral Pattern Analysis for Positive Margin Detection of Prostate Cancer Specimens using Light Reflectance Spectroscopy
TL;DR: This study applied data mining techniques on the light reflectance spectroscopy (LRS) data taken from ex-vivo human specimens and developed a novel classification algorithm that could enable real-time, positive-margin identification during surgery.
Journal ArticleDOI
Retroperitoneal Sclerosing Angiomyolipoma with Long-Term Follow up: A Case Report with Unique Clinicopathologic and Genomic Profile.
TL;DR: Sclerosing angiomyolipoma (sAML) is a rare variant of the perivascular epithelioid tumors exhibiting distinct morphology with extensive stromal hyalinization, which makes it challenging to recognise.
Journal ArticleDOI
Abstract 1234: PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer
Aditi Mulgaonkar,Layton Woolford,Roy Elias,Kien V. Nham,Bing Guan,Guiyang Hao,Christina Stevens,Vanina Tcheuyap,Sydney Haldeman,Jeffrey Miyata,Deyssy Carrillo,Qiang Qin,Nirmish Singla,I. Alex Bowman,Jeffrey A. Cadeddu,Vitaly Margulis,Alana Christie,Payal Kapur,Ivan Pedrosa,Marianna Dakanali,Orhan Oz,Xiankai Sun,James Brugarolas +22 more
TL;DR: Mulgaonkar et al. as discussed by the authors used positron emission tomography (PET) to assess program death ligand 1 (PD-L1) and its corresponding receptors in renal cell carcinoma (RCC) patients.